Results 181 to 190 of about 47,434 (363)

Brain metastasis in non‐small cell lung cancer: High‐risk factors and predictive models

VIEW, EarlyView.
Artificial intelligence (AI) can integrate of data to predict brain metastases (BM) in non‐small cell lung cancer (NSCLC). AI algorithms are employed to analyze these multifaceted datasets, enabling the identification of complex patterns and correlations that may not be apparent through traditional analytical methods.
Chen Gong, Ben Zhao, Shuangshuang Mao, Qingxu Liu, Yuanyuan Zhao, Yiwen Liu, Yao Luo, Qianxia Li   +7 more
wiley   +1 more source

Tumour‐informed workflow to use ctDNA as a biomarker for risk of recurrence in head and neck cancer patients post‐treatment

VIEW, EarlyView.
Our study presents a tumour‐informed circulating tumour DNA (ctDNA) workflow designed to enhance the detection of recurrence in head and neck cancer patients, addressing key challenges such as low ctDNA tumour fractions and tumour heterogeneity. Abstract Circulating tumour DNA (ctDNA) is a promising minimally invasive biomarker for monitoring treatment
Xiaomin Huang, Paul Leo, Mhairi Clout, Lynn Fink, Jonathan Ellis, Brett G. M. Hughes, Lizbeth Kenny, Sarju Vasani, Chamindie Punyadeera   +8 more
wiley   +1 more source

P3.02b-103 Identification of On-Target Mechanisms of Resistance to EGFR Inhibitors Using ctDNA Next-Generation Sequencing [PDF]

, 2017
W. Marston Linehan, Stephen R. Fairclough, Rebecca J. Nagy, Shirish M. Gadgeel, Matthew A. Gubens, Balázs Halmos, Suresh Ramalingam, Richard B. Lanman, Alice T. Shaw   +8 more
openalex   +1 more source

Artificial intelligence‐assisted theranostics for brain tumors: Advancements and future perspectives

VIEW, EarlyView.
Graphical demonstration of different applications of AIT for brain tumor. The major applications include CT and MRI‐based segmentation and analysis, histopathological analysis, precision treatment planning and prognosis, surgical and radiotherapy optimization, real‐time intratreatment monitoring, biomarker discovery, and molecular profiling for ...
Mifang Li, Lingyan Zhang, Zia Ullah, Yinghe Zhang, Shengxue Wei, Lihe Huang, Bing Guo   +6 more
wiley   +1 more source

P1.02-057 Clinical Utility of ctDNA for Detecting ALK Fusions and Resistance Events in NSCLC: Analysis of a Laboratory Cohort [PDF]

, 2017
Robert C. Doebele, Kimberly C. Banks, Nnamdi Ihuegbu, Joseph A. Diaz, Richard B. Lanman, Collin M. Blakely   +5 more
openalex   +1 more source

Survivorship Needs and Experiences of Survivors of Head and Neck Cancer in Rural Australia: A Qualitative Study

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Semi‐structured interviews with 17 rural head and neck cancer survivors revealed six main themes relating to their survivorship needs and experiences: 1) financial impacts, 2) physical effects, 3) psychosocial effects, 4) clinical management, 5) information and support needs, and 6) access.
Poorva Pradhan, Helen Hughes, Ashleigh R. Sharman, Judith Lacey, Patrick Dwyer, Jacques Hill, Kimberley J. Davis, Steven Craig, Raymond Wu, Bruce Ashford, Jenny Mitchell, Jonathan R. Clark, Michael Elliott, Carsten E. Palme, Rebecca L. Venchiarutti   +14 more
wiley   +1 more source

P2.03b-047 The Clinical Impact of Multiplex ctDNA Gene Analysis in Lung Cancer [PDF]

, 2017
Smadar Geva, Anna Belilovski Rozenblum, Maya Ilouze, Laila C. Roisman, Tal Twito, Addie Dvir, Lior Soussan‐Gutman, Elizabeth Dudnik, Alona Zer, Richard B. Lanman, Nir Peled   +10 more
openalex   +1 more source

The Current Status of Circulating Tumor DNA Utilization in Australasia: A Survey of Thoracic Oncology Group Australasia Members

Asia-Pacific Journal of Clinical Oncology, EarlyView.
This study explores the current status, utilization, and barriers to circulating tumour DNA (ctDNA) testing in thoracic oncology across Australia and New Zealand. While clinicians recognize the potential of ctDNA for guiding targeted therapy and monitoring disease, real‐world access remains inconsistent due to funding, availability, and infrastructure ...
Yifei Zhu, Danyon Lo, Deme Karikos, Malinda Itchins, Annie Wong   +4 more
wiley   +1 more source

P2.03b-093 Validation and Performance of a Standardized ctDNA NGS Assay across Two Laboratories [PDF]

, 2017
Tim Forshew, Andrew Lawson, Sarah Smalley, Vincent Plagnol, John D. Calaway, Shannon Blais, Karen Howarth, Greg Jones, Michelle Pugh, Mikidachi Madi, Bradley Durham, E. Musgrave-Brown, Sam Woodhouse, Nitzan Rosenfeld, Davina Gale, Emma Green, James Clark   +16 more
openalex   +1 more source

Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer

Annals of Oncology, 2022
D. Gale, K. Heider, A. Ruiz-Valdepeñas, S. Hackinger, M. Perry, G. Marsico, V. Rundell, J. Wulff, G. Sharma, H. Knock, J. Castedo, W. Cooper, H. Zhao, C.G. Smith, S. Garg, S. Anand, K. Howarth, D. Gilligan, S. Harden, D. Rassl, R. Rintoul, N. Rosenfeld   +21 more
semanticscholar   +1 more source